Select Filters
Apply Filters
Reset Filters

Regulatory T cells as a novel therapeutic target in Alzheimer's Disease

Alireza Faridar, M.D.
Houston, TX - United States
2021

Small molecule lysosome activator for the treatment of neurodegeneration

Lyndon Lien, Ph.D., M.B.A.
Hillsborough, CA - United States
2021

Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in FTLD-TDP

Peter Ljubenkov, M.D.
San Francisco, CA - United States
2021

High-Performance Plasma Phosphor-Tau Predicts Dementia, Tau and Amyloid PET

Tharick Ali Pascoal, M.D.
Pittsburgh, PA - United States
2020

Longitudinal changes in connectivity profiles across the AD spectrum

Kylie Alm, Ph.D.
Baltimore, MD - United States
2020

Assessing the Causal Role of Mitochondria in Alzheimer’s disease

Shea Andrews, Ph.D.
New York, NY - United States
2020

Blood Biomarkers for Prediction of Vascular Cognitive Impairment & Dementia

Hugo Aparicio, M.D., M.P.H.
Boston, MA - United States
2020

Validity of Functional Assessment Staging by Caregivers

Adriana Arcia, Ph.D., R.N.
New York, NY - United States
2020

BCG Immunization effects on Biomarkers of Inflammation/Immune Response and Alzheimer’s Disease

Steven Arnold, M.D.
Boston, MA - United States
2020

Investigating a Neuroprotective Pathway in Alzheimer's Disease

Scott Ayton, Ph.D.
Parkville, Australia
2020

Sex Biology of Alzheimer's: Cognition, Risk and Tau

Sarah Banks, Ph.D.
La Jolla, CA - United States
2020

Tau pathology and propagation in a monkey model of Alzheimer's disease

Danielle Beckman, Ph.D.
Davis, CA - United States
2020

Elucidation of Early Circuit Dysfunction in Alzheimer's Disease Pathogenesis

Kevin Beier, Ph.D.
Irvine, CA - United States
2020

Putting the Pieces Together: APOE, Age, Sex, and Ancestry in AD Genetics

Michaël Belloy, Ph.D.
Redwood City, CA - United States
2020

Safety and efficacy of Maraviroc in vascular cognitive impairment

Einor Ben Assayag, Ph.D., and Hen Hallevi, M.D.
Tel-Aviv, Israel
2020

Rhythm for Life - a training for creative musical interaction in dementia

Jane Bentley, Ph.D.
Paisley, United Kingdom
2020

Aromatase inhibition in Alzheimer's disease: Phase 2 study

Anat Biegon, Ph.D.
Stony Brook, NY - United States
2020

Preventable Burden of Dementia in South Africa

Kirsty Bobrow, DPhil
San Francisco, CA - United States
2020

Why Participate: Exploring Motives to Participate in Prevention Research

Laura Booi, Ph.D.
Newcastle upon Tyne, United Kingdom
2020

Modulation of Hippocampal Cicuitry with Focused Ultrasound in MCI

Susan Bookheimer, Ph.D.
Los Angeles, CA - United States
2020

Exploring the Power of Active Clowning in Aphasia Intervention

Lenisa Brandao, Ph.D.
Porto Alegre, Brazil
2020

Moving Pictures: Using digital media to improve dementia care in India

Bianca Brijnath, Ph.D.
Melbourne, Australia
2020

Sex, tau accumulation, and the role of menopause in AD pathogenesis

Rachel Buckley, Ph.D.
Boston, MA - United States
2020

Do Lifestyles Induce Cell Plasticity? A Molecular Query Across Human Trials

Kaitlin Casaletto, Ph.D.
San Francisco, CA - United States
2020

My Life My Way – a CLEAR© model for Dementia Care

Siobhan Casey, BA Hons.
Dublin, Ireland
2020

Phase 1 study of a novel device reducing vascular contributions to dementia

David Celermajer, Ph.D., M.B.B.S
Paddington, Australia
2020

TauC3: A key tauopathy culprit and an antibody to mitigate its effects

Daniel Chain, Ph.D.
London, United Kingdom
2020

CSF1R inhibitor EI071 for modulating microglia-associated neuroinflammation

Hung-Kai Chen, M.D., Ph.D.
Taipei, Taiwan
2020

The Magdalena Project; erasing stigma around aging and dementia

Gabri Christa, MFA
New York, NY - United States
2020

Clinical Relevance of a Widespread NOTCH3 Mutation for CADASIL Pathogenesis

Marina Ciullo, Ph.D.
Naples, Italy
2020

1 2 3 4 5 6 7 8 9 10... >|